A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists

被引：0

作者：

Banerjee, Pooja S. ^{[1
]}

Samanta, Subir ^{[1
]}

机构：

[1] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi, Bihar, India

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2013年 / 13卷 / 05期

关键词：

Natural ligands; Pharmacophore; PPAR gamma; Synthetic ligands; Thiazolidinediones; Type II Diabetes; LIGAND-BINDING; HYPOLIPIDEMIC AGENTS; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; RECEPTOR; ALPHA; ROSIGLITAZONE; GLITAZONES; SERIES; LIVER;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Peroxisome Proliferator Activated Receptors gamma (PPAR) are a class of ligand activated transcription factors with a prominent role in the regulation of metabolic processes. The present work aims towards examining the functional and structural features that facilitate the binding of small molecules based on Thiazolidinedione pharmacophore to PPARs. The intent of this article is to review all the reported thiazolidinediones and associated groups of PPAR gamma ligands.

引用

页码：706 / 712

页数：7

共 50 条

[21] PPAR gamma agonists and the role of VEGF in the development of oedema
Chee, R
Kaye, D
Chin-Dusting, JPF
Moe, K
JOURNAL OF HYPERTENSION, 2004, 22 : S284 - S285
[22] PPAR receptors and insulin sensitivity:: new agonists in development
Pégorier, JP
ANNALES D ENDOCRINOLOGIE, 2005, 66 (02) : S10 - S17
[23] Discovery of new PPARγ agonists based on arylopeptoids
Worm-Leonhard, Kasper
Hjelmgaard, Thomas
Petersen, Rasmus K.
Kristiansen, Karsten
Nielsen, John
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4162 - 4165
[24] Promotion of colon tumors in C57BL/6J-APCmin/+ mice by thiazolidinedione PPARγ agonists and a structurally unrelated PPARγ agonist
Pino, MV
Kelley, MF
Jayyosi, Z
TOXICOLOGIC PATHOLOGY, 2004, 32 (01) : 58 - 63
[25] Novel class of aryl thiazolidinedione PPAR agonists as insulin sensitizing agents for the treatment of Type II diabetes mellitus.
Boueres, JK
Han, W
Santini, C
Liang, CO
Tolman, RL
McNaul, KL
Berger, JP
Zhou, GC
Doebber, TW
Moller, DE
Sahoo, SP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U42 - U43
[26] The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review
Liu, Yu
Wang, Jiayu
Luo, Shuangyan
Zhan, Yi
Lu, Qianjin
JOURNAL OF AUTOIMMUNITY, 2020, 113
[27] Are physiological clonal expansion and maturation pathways a basis for discrepant behaviour of colon tumoral cell growth in response to the thiazolidinedione PPARγ agonists?: Commentary
Vamecq, J
Latruffe, N
ONCOLOGY REPORTS, 1999, 6 (06) : 1281 - 1283
[28] Inverse association of PPARγ agonists use and high grade glioma development
Christian Grommes
Devon S. Conway
Amer Alshekhlee
Jill S. Barnholtz-Sloan
Journal of Neuro-Oncology, 2010, 100 : 233 - 239
[29] Inverse association of PPARγ agonists use and high grade glioma development
Grommes, Christian
Conway, Devon S.
Alshekhlee, Amer
Barnholtz-Sloan, Jill S.
JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (02) : 233 - 239
[30] Synergistic potential for treatment of mice with an established intracerebral glioma by combining PPAR-γ thiazolidinedione agonists and IL-2 secreting fibroblasts
Lichtor, Terry
Glick, Roberta P.
Spagnolo, Alessandra
Cohen, Edward P.
Feinstein, Douglas L.
NEURO-ONCOLOGY, 2006, 8 (04) : 429 - 429

← 1 2 3 4 5 →